With Shkreli gone, HRC calls on maker of Daraprim to act immediately
WASHINGTON — Following the news that Martin Shkreli has resigned as CEO of Turing Pharmaceuticals, the Human Rights Campaign (HRC), called on the drug maker’s interim CEO Ron Tilles to immediately reduce the cost of the life-saving drug Daraprim to its original price. “We hope that Martin Shkreli’s departure will mark the end of Turing…
